Cortica Funding, Investors & Competitors

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

Cerebral is a US-based telemedicine provider offering mental health care for anxiety, depression, and ADHD. Headquartered in San Francisco, it connects patients with licensed therapists and prescribers via app for medication management and therapy sessions. The platform serves all 50 states with insurance billing for Aetna and Cigna. Cerebral uses evidence-based protocols like CBT and follows APA guidelines. Launched in 2020, it expanded to couples counseling.

Grow Therapy is a New York-headquartered online platform connecting clients with licensed mental health providers across all 50 U.S. states. It handles credentialing, billing, and insurance claims for in-network therapists, integrating with Aetna, Cigna, Medicare, Medicaid, and UnitedHealthcare among 100-plus payers. The service delivers matched referrals, business tools, peer communities, and continuing education events to independent practitioners. Supporting thousands of therapists serving over 1 million clients, Grow Therapy raised $178 million from investors including Sequoia Capital and Goldman Sachs Alternatives.

Headway is a virtual mental health platform connecting patients with licensed therapists who accept insurance. New York-headquartered Headway streamlines booking for video or in-person sessions across all 50 U.S. states. The platform verifies provider credentials, handles billing with major insurers like Aetna and UnitedHealthcare, and supports 200 therapy specialties including anxiety and trauma. Launched in 2019, Headway serves over 10 million covered lives, enabling practices to scale through technology.

Nourish is a virtual nutrition care provider using AI to deliver insurance-covered dietitian services addressing chronic diseases. New York-headquartered since 2020, it matches patients with registered dietitians for personalized plans covered by Medicare and major plans, focusing on diabetes, hypertension, and weight management.

Apricus Health is a telehealth provider offering direct primary care memberships with 24/7 access to physicians and navigators for diagnosing common conditions like infections, hypertension, and mental health issues. Available nationwide via app and video, it covers virtual visits, prescriptions, labs, and chronic disease management without insurance requirements. Apricus emphasizes personalized plans and preventive screenings.

Elemy is a provider of in-home behavioral and mental healthcare for children nationwide. Denver-headquartered, it launched autism care services in April 2020 before expanding to ADHD, OCD, anxiety, depression, social anxiety, and bipolar disorder. The platform integrates telehealth scheduling, progress tracking, and multidisciplinary teams of therapists, behavior analysts, and psychiatrists delivering whole-child treatment models. Elemy partners with insurers like UnitedHealthcare and Aetna, focusing on underserved families in 25 states with outcomes including doubled therapy adherence rates.

SonderMind is a Denver-headquartered teletherapy platform founded in 2017 that matches patients with licensed therapists across 50 states. Its network includes 3,000 providers specializing in anxiety, depression, and trauma, serving 200,000 sessions monthly for individuals, employers, and health plans like Aetna. The platform handles billing, scheduling, and outcomes tracking via HIPAA-compliant software. SonderMind operates in partnership with 100 corporate clients and reports 85 percent client retention through personalized matching algorithms.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.

Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.